Tango Therapeutics, Inc. (TNGX) Total liabilities 2020–2025
Tango Therapeutics, Inc. (TNGX) total liabilities at each fiscal year-end, per SEC filings.
$52.5MFY2025 · since FY2020: $168.7M → $52.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $52.5M | -55.1% |
| FY2024 | $117.0M | -21.7% |
| FY2023 | $149.5M | -20.1% |
| FY2022 | $187.0M | +20.3% |
| FY2021 | $155.4M | -7.9% |
| FY2020 | $168.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice